
Oct 27, 2026
Early progress on accelerating drug development with Claude
Anthropic's life sciences team is making strides in accelerating drug development through innovative partnerships and AI integration.Over the past few months, Anthropic has collaborated with six organizations—including BigHat Biosciences and Bristol Myers Squibb—to enhance drug discovery processes. Their approach involves leveraging AI, specifically Claude, across various stages of drug development, from initial research to regulatory filings. The team has identified that the challenges in drug




